Beta-blocker therapy and the risk of anaphylaxis. - Wikidata - awgldk - TriplyDB

Beta-blocker therapy and the risk of anaphylaxis.

Beta-blocker therapy and the risk of anaphylaxis.

http://www.wikidata.org/entity/Q34731105

about

Navigating the updated anaphylaxis parameters.Aspirin hypersensitivity and desensitization protocols: implications for cardiac patients The risk and management of anaphylaxis in the setting of immunotherapy.

P2860

Q33864947-0E12C063-E98A-40CC-AFF0-D13CC0507BDA Q33949371-E26C9F6E-EF26-4517-A77D-3DE71884123E Q38066677-5893FE8A-7764-4C28-AB64-FB48290EB662

P2860

Beta-blocker therapy and the risk of anaphylaxis.

http://www.wikidata.org/entity/Q34731105

description

1987 nî lūn-bûn

@nan

1987 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Beta-blocker therapy and the risk of anaphylaxis.

@ast

Beta-blocker therapy and the risk of anaphylaxis.

@en

Beta-blocker therapy and the risk of anaphylaxis.

@nl

type

label

Beta-blocker therapy and the risk of anaphylaxis.

@ast

Beta-blocker therapy and the risk of anaphylaxis.

@en

Beta-blocker therapy and the risk of anaphylaxis.

@nl

prefLabel

Beta-blocker therapy and the risk of anaphylaxis.

@ast

Beta-blocker therapy and the risk of anaphylaxis.

@en

Beta-blocker therapy and the risk of anaphylaxis.

@nl

P1433

Q34731105-F6EDFDBF-4AC6-4E35-ADC4-ADD989230280

P1476

Q34731105-E9ACB853-EA8F-4974-8A0A-58D6F5561A36

P2093

Q34731105-968077F2-053C-46AF-BDD5-0530B6AECB90

P2860

Q34731105-027494A6-7F55-4E02-8D94-74E07C9D0398

Q34731105-0B08B2C6-EFF9-4A38-B139-7F07CED029B6

Q34731105-1B987742-4BCA-4668-9319-98CFC575A05F

Q34731105-21614C52-6382-451C-9C5A-EB82D89EC235

Q34731105-3DDD0F9D-9A72-44CD-9085-54186C9D9B83

Q34731105-4D8BFFA8-B3A8-449B-9AB3-AE928C341DB3

Q34731105-4DCB6AEE-D8D7-4370-98E3-0DCA165056C8

Q34731105-57B8ABD1-CAAF-4335-B904-6505ED449D34

Q34731105-6532B0A9-2546-4B1D-AFAC-3988528C8E95

Q34731105-8416DF46-3E43-431C-9469-3C0C62DCE5BD

P304

Q34731105-6FE3EF9E-6F74-4969-B1CD-13DAFC111F2B

P31

Q34731105-848C1640-B2FE-493A-BC64-AB5F1594E813

P407

Q34731105-643C2A26-551F-4B38-9D78-50B459D4EFA5

P433

Q34731105-5606C477-2AA5-44ED-868E-84CA76A21FD9

P478

Q34731105-9E7AD18F-EDD1-4D3D-8BCC-50935F67D8E2

P577

Q34731105-B5FE5D0B-619D-4C21-926E-EBF19D6B8CF4

P698

Q34731105-EEF1D01A-4BAA-4BF2-9644-09AF864A6594

P921

Q34731105-834E089E-0292-4FE8-83DB-715F01DFB854

P932

Q34731105-11FB4E7A-C68D-4A54-9C3A-010CF251B151

P1433

Canadian Medical Association Journal

P1476

Beta-blocker therapy and the risk of anaphylaxis.

@en

P2093

Toogood JH

http://www.w3.org/2001/XMLSchema#string

P2860

Severe hypertension produced by interaction of phenylpropanolamine with methyldopa and oxprenolol

Severe adverse reactions to urography in patients taking beta-adrenergic blocking agents.

Hazards of phenylephrine topical medication in persons taking propranolol.

Histamine hypersensitivity in mice induced by Bordetella pertussis or pharmacologic beta adrenergic blockade. Effects of adrenergic, cholinergic, and other drugs.

The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.

Distribution oand pharmacological release of histamine in canine lung in vivo.

The nature of the beta-adrenoceptor involved in the inhibition of antigen-induced histamine release.

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.

Hypersensitivity to histamine and systemic anaphylaxis in mice with pharmacologic beta adrenergic blockade: protection by nucleotides.

Decreased granulocyte response to isoproterenol in asthma during upper respiratory infections.

P304

929-933

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P577

1987-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2882832

http://www.w3.org/2001/XMLSchema#string

P921

P932

1491970

http://www.w3.org/2001/XMLSchema#string